“Upstream” Reach of the Federal Anti-kickback Statute
January 25, 2020
AMARILLO, TX – The federal anti-kickback statute (“AKS”) makes it a felony to knowingly and willfully offer, pay, solicit, or receive any remuneration to induce a person or entity to refer an individual for the furnishing or arranging for t
Bring Your A/R and Intake Staff to Learn at Medtrade Spring
January 18, 2020
LAS VEGAS – Everyone loves the show floor at Medtrade Spring, but those educational sessions have a whole lot to offer. For example, the Medtrade Spring conference program includes sessions that address topics important to your A/R and Intake staff
Fraud and Abuse Laws: Cliffs Notes Version
January 18, 2020
AMARILLO, TX – DME suppliers operate in a highly regulated environment. Suppliers must comply with (i) federal anti-fraud laws, (ii) state anti-fraud laws, (iii) supplier standards, (iv) accreditation requirements, and (v) guidance from Medicar
Accessing Another Supplier’s Commercial Insurance Contract
January 4, 2020
AMARILLO, TX – Approximately (i) 35% of all Medicare patients are covered by Medicare Advantage Plans (“MAPs”) and (ii) 70% of all state Medicaid patients are covered by Medicaid Managed Care Plans (“MMCPs”). These percentages are incre
Lab Kickback Settlement: Lessons for DME Suppliers
December 29, 2019
AMARILLO, TX – According to a recent Department of Justice (“DOJ”) Press Release, Boston Heart Diagnostics Corporation (“BHDC”), a Framingham, MA lab, has agreed to pay $26.67 million to resolve False Claims Act (“FCA”) allegations
Cannabidiol (“CBD”): A Primer – Part 2
December 13, 2019
AMARILLO, TX – As I mentioned in last week’s Part One, this may seem like a strange article to write for DME suppliers. However, an increasing number of DME suppliers (like pharmacies, health food stores, and others) are looking at the potent